The global Injectable Deoxycholic Acid market was valued at US$ 418 million in 2025 and is anticipated to reach US$ 1095 million by 2032, at a CAGR of 15.8% from 2026 to 2032.

Injectable Deoxycholic Acid Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Injectable Deoxycholic Acid competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Injectable deoxycholic acid is a synthetic form of a naturally occurring secondary bile acid found in the human body. Clinically defined as a non-surgical cytolytic agent or lipolytic injectable, it works by physically disrupting the cell membrane of adipocytes (fat cells)—a process known as adipocytolysis. Once the fat cell membrane is destroyed, the cellular debris is cleared through the body's natural metabolic pathways, effectively reducing localized subcutaneous fat deposits, such as submental (double chin) fat. In 2025, global sales of injectable deoxycholic acid will reach 720,000 vials, with an average selling price of US$580 per vial. The supply chain of injectable deoxycholic acid is composed of upstream raw material R&D, midstream formulation manufacturing, and downstream clinical application. The upstream focuses on the production of high-purity Active Pharmaceutical Ingredients (API), utilizing complex chemical synthesis or bio-extraction to provide deoxycholic acid powder that meets pharmacopeia or medical-grade standards. The midstream is the core of the chain, where manufacturers with pharmaceutical or medical device licenses formulate the raw materials into sterile injectables through processes like aseptic blending, micro-encapsulation, or compound formulation, followed by regulatory validation and branding. The downstream involves pharmaceutical distribution and medical aesthetic clinics, where professional practitioners perform precise injections to achieve physical fat cell dissolution and metabolic clearance for end-users.

The North American market for Injectable Deoxycholic Acid is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Injectable Deoxycholic Acid is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Injectable Deoxycholic Acid include AbbVie (Kybella), Dermax, ICE Pharma, DEXLEVO(Kabelline), LG Chem(Bellacholine), Espad Pharmed, Curia, Marllor Biomedical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Injectable Deoxycholic Acid market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Injectable Deoxycholic Acid. The Injectable Deoxycholic Acid market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Injectable Deoxycholic Acid market comprehensively. Regional market sizes by Type, by Application, by Compliance Level, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Injectable Deoxycholic Acid manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Injectable Deoxycholic Acid Market Report

Report Metric	Details
Report Name	Injectable Deoxycholic Acid Market
Accounted market size in 2025	US$ 418 million
Forecasted market size in 2032	US$ 1095 million
CAGR	15.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Pure Deoxycholic Acid Compound Formulations
Segment by Compliance Level	Pharmaceutical Grade Medical Device Grade Cosmetic Grade
by Application	Dermatology Clinics Hospitals Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AbbVie (Kybella), Dermax, ICE Pharma, DEXLEVO(Kabelline), LG Chem(Bellacholine), Espad Pharmed, Curia, Marllor Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Compliance Level, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Injectable Deoxycholic Acid manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Injectable Deoxycholic Acid sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Injectable Deoxycholic Acid Market growing?

Ans: The Injectable Deoxycholic Acid Market witnessing a CAGR of 15.8% during the forecast period 2026-2032.

What is the Injectable Deoxycholic Acid Market size in 2032?

Ans: The Injectable Deoxycholic Acid Market size in 2032 will be US$ 1095 million.

Who are the main players in the Injectable Deoxycholic Acid Market report?

Ans: The main players in the Injectable Deoxycholic Acid Market are AbbVie (Kybella), Dermax, ICE Pharma, DEXLEVO(Kabelline), LG Chem(Bellacholine), Espad Pharmed, Curia, Marllor Biomedical

What are the Application segmentation covered in the Injectable Deoxycholic Acid Market report?

Ans: The Applications covered in the Injectable Deoxycholic Acid Market report are Dermatology Clinics, Hospitals, Others

What are the Type segmentation covered in the Injectable Deoxycholic Acid Market report?

Ans: The Types covered in the Injectable Deoxycholic Acid Market report are Pure Deoxycholic Acid, Compound Formulations

1 Injectable Deoxycholic Acid Market Overview

1.1 Product Definition

1.2 Injectable Deoxycholic Acid by Type

1.2.1 Global Injectable Deoxycholic Acid Market Value by Type: 2025 vs 2032

1.2.2 Pure Deoxycholic Acid

1.2.3 Compound Formulations

1.3 Injectable Deoxycholic Acid by Compliance Level

1.3.1 Global Injectable Deoxycholic Acid Market Value by Compliance Level: 2025 vs 2032

1.3.2 Pharmaceutical Grade

1.3.3 Medical Device Grade

1.3.4 Cosmetic Grade

1.4 Injectable Deoxycholic Acid by Application

1.4.1 Global Injectable Deoxycholic Acid Market Value by Application: 2025 vs 2032

1.4.2 Dermatology Clinics

1.4.3 Hospitals

1.4.4 Others

1.5 Global Injectable Deoxycholic Acid Market Size Estimates and Forecasts

1.5.1 Global Injectable Deoxycholic Acid Revenue 2021–2032

1.5.2 Global Injectable Deoxycholic Acid Sales 2021–2032

1.5.3 Global Injectable Deoxycholic Acid Market Average Price (2021–2032)

1.6 Assumptions and Limitations

2 Injectable Deoxycholic Acid Market Competition by Manufacturers

2.1 Global Injectable Deoxycholic Acid Sales Market Share by Manufacturers (2021–2026)

2.2 Global Injectable Deoxycholic Acid Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Injectable Deoxycholic Acid Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Injectable Deoxycholic Acid, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Injectable Deoxycholic Acid, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Injectable Deoxycholic Acid, Product Types and Applications

2.7 Global Key Manufacturers of Injectable Deoxycholic Acid, Date of Entry into the Industry

2.8 Global Injectable Deoxycholic Acid Market Competitive Situation and Trends

2.8.1 Global Injectable Deoxycholic Acid Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Injectable Deoxycholic Acid Players Market Share by Revenue

2.8.3 Global Injectable Deoxycholic Acid Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Injectable Deoxycholic Acid Market Scenario by Region

3.1 Global Injectable Deoxycholic Acid Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Injectable Deoxycholic Acid Sales by Region: 2021–2032

3.2.1 Global Injectable Deoxycholic Acid Sales by Region: 2021–2026

3.2.2 Global Injectable Deoxycholic Acid Sales by Region: 2027–2032

3.3 Global Injectable Deoxycholic Acid Revenue by Region: 2021–2032

3.3.1 Global Injectable Deoxycholic Acid Revenue by Region: 2021–2026

3.3.2 Global Injectable Deoxycholic Acid Revenue by Region: 2027–2032

3.4 North America Injectable Deoxycholic Acid Market Facts & Figures by Country

3.4.1 North America Injectable Deoxycholic Acid Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Injectable Deoxycholic Acid Sales by Country (2021–2032)

3.4.3 North America Injectable Deoxycholic Acid Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Injectable Deoxycholic Acid Market Facts & Figures by Country

3.5.1 Europe Injectable Deoxycholic Acid Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Injectable Deoxycholic Acid Sales by Country (2021–2032)

3.5.3 Europe Injectable Deoxycholic Acid Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Injectable Deoxycholic Acid Market Facts & Figures by Region

3.6.1 Asia Pacific Injectable Deoxycholic Acid Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Injectable Deoxycholic Acid Sales by Region (2021–2032)

3.6.3 Asia Pacific Injectable Deoxycholic Acid Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Injectable Deoxycholic Acid Market Facts & Figures by Country

3.7.1 Latin America Injectable Deoxycholic Acid Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Injectable Deoxycholic Acid Sales by Country (2021–2032)

3.7.3 Latin America Injectable Deoxycholic Acid Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Injectable Deoxycholic Acid Market Facts & Figures by Country

3.8.1 Middle East and Africa Injectable Deoxycholic Acid Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Injectable Deoxycholic Acid Sales by Country (2021–2032)

3.8.3 Middle East and Africa Injectable Deoxycholic Acid Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Injectable Deoxycholic Acid Sales by Type (2021–2032)

4.1.1 Global Injectable Deoxycholic Acid Sales by Type (2021–2026)

4.1.2 Global Injectable Deoxycholic Acid Sales by Type (2027–2032)

4.1.3 Global Injectable Deoxycholic Acid Sales Market Share by Type (2021–2032)

4.2 Global Injectable Deoxycholic Acid Revenue by Type (2021–2032)

4.2.1 Global Injectable Deoxycholic Acid Revenue by Type (2021–2026)

4.2.2 Global Injectable Deoxycholic Acid Revenue by Type (2027–2032)

4.2.3 Global Injectable Deoxycholic Acid Revenue Market Share by Type (2021–2032)

4.3 Global Injectable Deoxycholic Acid Price by Type (2021–2032)

5 Segment by Application

5.1 Global Injectable Deoxycholic Acid Sales by Application (2021–2032)

5.1.1 Global Injectable Deoxycholic Acid Sales by Application (2021–2026)

5.1.2 Global Injectable Deoxycholic Acid Sales by Application (2027–2032)

5.1.3 Global Injectable Deoxycholic Acid Sales Market Share by Application (2021–2032)

5.2 Global Injectable Deoxycholic Acid Revenue by Application (2021–2032)

5.2.1 Global Injectable Deoxycholic Acid Revenue by Application (2021–2026)

5.2.2 Global Injectable Deoxycholic Acid Revenue by Application (2027–2032)

5.2.3 Global Injectable Deoxycholic Acid Revenue Market Share by Application (2021–2032)

5.3 Global Injectable Deoxycholic Acid Price by Application (2021–2032)

6 Key Companies Profiled

6.1 AbbVie (Kybella)

6.1.1 AbbVie (Kybella) Company Information

6.1.2 AbbVie (Kybella) Description and Business Overview

6.1.3 AbbVie (Kybella) Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 AbbVie (Kybella) Injectable Deoxycholic Acid Product Portfolio

6.1.5 AbbVie (Kybella) Recent Developments/Updates

6.2 Dermax

6.2.1 Dermax Company Information

6.2.2 Dermax Description and Business Overview

6.2.3 Dermax Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Dermax Injectable Deoxycholic Acid Product Portfolio

6.2.5 Dermax Recent Developments/Updates

6.3 ICE Pharma

6.3.1 ICE Pharma Company Information

6.3.2 ICE Pharma Description and Business Overview

6.3.3 ICE Pharma Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 ICE Pharma Injectable Deoxycholic Acid Product Portfolio

6.3.5 ICE Pharma Recent Developments/Updates

6.4 DEXLEVO(Kabelline)

6.4.1 DEXLEVO(Kabelline) Company Information

6.4.2 DEXLEVO(Kabelline) Description and Business Overview

6.4.3 DEXLEVO(Kabelline) Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 DEXLEVO(Kabelline) Injectable Deoxycholic Acid Product Portfolio

6.4.5 DEXLEVO(Kabelline) Recent Developments/Updates

6.5 LG Chem(Bellacholine)

6.5.1 LG Chem(Bellacholine) Company Information

6.5.2 LG Chem(Bellacholine) Description and Business Overview

6.5.3 LG Chem(Bellacholine) Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 LG Chem(Bellacholine) Injectable Deoxycholic Acid Product Portfolio

6.5.5 LG Chem(Bellacholine) Recent Developments/Updates

6.6 Espad Pharmed

6.6.1 Espad Pharmed Company Information

6.6.2 Espad Pharmed Description and Business Overview

6.6.3 Espad Pharmed Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Espad Pharmed Injectable Deoxycholic Acid Product Portfolio

6.6.5 Espad Pharmed Recent Developments/Updates

6.7 Curia

6.7.1 Curia Company Information

6.7.2 Curia Description and Business Overview

6.7.3 Curia Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Curia Injectable Deoxycholic Acid Product Portfolio

6.7.5 Curia Recent Developments/Updates

6.8 Marllor Biomedical

6.8.1 Marllor Biomedical Company Information

6.8.2 Marllor Biomedical Description and Business Overview

6.8.3 Marllor Biomedical Injectable Deoxycholic Acid Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Marllor Biomedical Injectable Deoxycholic Acid Product Portfolio

6.8.5 Marllor Biomedical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Injectable Deoxycholic Acid Industry Chain Analysis

7.2 Injectable Deoxycholic Acid Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Injectable Deoxycholic Acid Production Mode & Process Analysis

7.4 Injectable Deoxycholic Acid Sales and Marketing

7.4.1 Injectable Deoxycholic Acid Sales Channels

7.4.2 Injectable Deoxycholic Acid Distributors

7.5 Injectable Deoxycholic Acid Customer Analysis

8 Injectable Deoxycholic Acid Market Dynamics

8.1 Injectable Deoxycholic Acid Industry Trends

8.2 Injectable Deoxycholic Acid Market Drivers

8.3 Injectable Deoxycholic Acid Market Challenges

8.4 Injectable Deoxycholic Acid Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

LG Chem(Bellacholine)

Espad Pharmed

List of Tables

Table 1. Global Injectable Deoxycholic Acid Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Injectable Deoxycholic Acid Market Value by Compliance Level (US$ Million), 2025 vs 2032

Table 3. Global Injectable Deoxycholic Acid Market Value by Application (US$ Million), 2025 vs 2032

Table 4. Global Injectable Deoxycholic Acid Market Competitive Situation by Manufacturers in 2025

Table 5. Global Injectable Deoxycholic Acid Sales (K Units) of Key Manufacturers (2021–2026)

Table 6. Global Injectable Deoxycholic Acid Sales Market Share by Manufacturers (2021–2026)

Table 7. Global Injectable Deoxycholic Acid Revenue (US$ Million) by Manufacturers (2021–2026)

Table 8. Global Injectable Deoxycholic Acid Revenue Share by Manufacturers (2021–2026)

Table 9. Global Market Injectable Deoxycholic Acid Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 10. Global Key Players of Injectable Deoxycholic Acid, Industry Ranking, 2023 vs 2024 vs 2025

Table 11. Global Key Manufacturers of Injectable Deoxycholic Acid, Manufacturing Sites and Headquarters

Table 12. Global Key Manufacturers of Injectable Deoxycholic Acid, Product Types and Applications

Table 13. Global Key Manufacturers of Injectable Deoxycholic Acid, Date of Entry into the Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Injectable Deoxycholic Acid Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injectable Deoxycholic Acid Revenue, 2025

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Injectable Deoxycholic Acid Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Injectable Deoxycholic Acid Sales by Region (K Units), 2021–2026

Table 19. Global Injectable Deoxycholic Acid Sales Market Share by Region (2021–2026)

Table 20. Global Injectable Deoxycholic Acid Sales by Region (K Units), 2027–2032

Table 21. Global Injectable Deoxycholic Acid Sales Market Share by Region (2027–2032)

Table 22. Global Injectable Deoxycholic Acid Revenue by Region (US$ Million), 2021–2026

Table 23. Global Injectable Deoxycholic Acid Revenue Market Share by Region (2021–2026)

Table 24. Global Injectable Deoxycholic Acid Revenue by Region (US$ Million), 2027–2032

Table 25. Global Injectable Deoxycholic Acid Revenue Market Share by Region (2027–2032)

Table 26. North America Injectable Deoxycholic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 27. North America Injectable Deoxycholic Acid Sales by Country (K Units), 2021–2026

Table 28. North America Injectable Deoxycholic Acid Sales by Country (K Units), 2027–2032

Table 29. North America Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2021–2026

Table 30. North America Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2027–2032

Table 31. Europe Injectable Deoxycholic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 32. Europe Injectable Deoxycholic Acid Sales by Country (K Units), 2021–2026

Table 33. Europe Injectable Deoxycholic Acid Sales by Country (K Units), 2027–2032

Table 34. Europe Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2021–2026

Table 35. Europe Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2027–2032

Table 36. Asia Pacific Injectable Deoxycholic Acid Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia Pacific Injectable Deoxycholic Acid Sales by Region (K Units), 2021–2026

Table 38. Asia Pacific Injectable Deoxycholic Acid Sales by Region (K Units), 2027–2032

Table 39. Asia Pacific Injectable Deoxycholic Acid Revenue by Region (US$ Million), 2021–2026

Table 40. Asia Pacific Injectable Deoxycholic Acid Revenue by Region (US$ Million), 2027–2032

Table 41. Latin America Injectable Deoxycholic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 42. Latin America Injectable Deoxycholic Acid Sales by Country (K Units), 2021–2026

Table 43. Latin America Injectable Deoxycholic Acid Sales by Country (K Units), 2027–2032

Table 44. Latin America Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2021–2026

Table 45. Latin America Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2027–2032

Table 46. Middle East and Africa Injectable Deoxycholic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 47. Middle East and Africa Injectable Deoxycholic Acid Sales by Country (K Units), 2021–2026

Table 48. Middle East and Africa Injectable Deoxycholic Acid Sales by Country (K Units), 2027–2032

Table 49. Middle East and Africa Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2021–2026

Table 50. Middle East and Africa Injectable Deoxycholic Acid Revenue by Country (US$ Million), 2027–2032

Table 51. Global Injectable Deoxycholic Acid Sales (K Units) by Type (2021–2026)

Table 52. Global Injectable Deoxycholic Acid Sales (K Units) by Type (2027–2032)

Table 53. Global Injectable Deoxycholic Acid Sales Market Share by Type (2021–2026)

Table 54. Global Injectable Deoxycholic Acid Sales Market Share by Type (2027–2032)

Table 55. Global Injectable Deoxycholic Acid Revenue (US$ Million) by Type (2021–2026)

Table 56. Global Injectable Deoxycholic Acid Revenue (US$ Million) by Type (2027–2032)

Table 57. Global Injectable Deoxycholic Acid Revenue Market Share by Type (2021–2026)

Table 58. Global Injectable Deoxycholic Acid Revenue Market Share by Type (2027–2032)

Table 59. Global Injectable Deoxycholic Acid Price (US$/Unit) by Type (2021–2026)

Table 60. Global Injectable Deoxycholic Acid Price (US$/Unit) by Type (2027–2032)

Table 61. Global Injectable Deoxycholic Acid Sales (K Units) by Application (2021–2026)

Table 62. Global Injectable Deoxycholic Acid Sales (K Units) by Application (2027–2032)

Table 63. Global Injectable Deoxycholic Acid Sales Market Share by Application (2021–2026)

Table 64. Global Injectable Deoxycholic Acid Sales Market Share by Application (2027–2032)

Table 65. Global Injectable Deoxycholic Acid Revenue (US$ Million) by Application (2021–2026)

Table 66. Global Injectable Deoxycholic Acid Revenue (US$ Million) by Application (2027–2032)

Table 67. Global Injectable Deoxycholic Acid Revenue Market Share by Application (2021–2026)

Table 68. Global Injectable Deoxycholic Acid Revenue Market Share by Application (2027–2032)

Table 69. Global Injectable Deoxycholic Acid Price (US$/Unit) by Application (2021–2026)

Table 70. Global Injectable Deoxycholic Acid Price (US$/Unit) by Application (2027–2032)

Table 71. AbbVie (Kybella) Company Information

Table 72. AbbVie (Kybella) Description and Business Overview

Table 73. AbbVie (Kybella) Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 74. AbbVie (Kybella) Injectable Deoxycholic Acid Product

Table 75. AbbVie (Kybella) Recent Developments/Updates

Table 76. Dermax Company Information

Table 77. Dermax Description and Business Overview

Table 78. Dermax Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 79. Dermax Injectable Deoxycholic Acid Product

Table 80. Dermax Recent Developments/Updates

Table 81. ICE Pharma Company Information

Table 82. ICE Pharma Description and Business Overview

Table 83. ICE Pharma Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 84. ICE Pharma Injectable Deoxycholic Acid Product

Table 85. ICE Pharma Recent Developments/Updates

Table 86. DEXLEVO(Kabelline) Company Information

Table 87. DEXLEVO(Kabelline) Description and Business Overview

Table 88. DEXLEVO(Kabelline) Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 89. DEXLEVO(Kabelline) Injectable Deoxycholic Acid Product

Table 90. DEXLEVO(Kabelline) Recent Developments/Updates

Table 91. LG Chem(Bellacholine) Company Information

Table 92. LG Chem(Bellacholine) Description and Business Overview

Table 93. LG Chem(Bellacholine) Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 94. LG Chem(Bellacholine) Injectable Deoxycholic Acid Product

Table 95. LG Chem(Bellacholine) Recent Developments/Updates

Table 96. Espad Pharmed Company Information

Table 97. Espad Pharmed Description and Business Overview

Table 98. Espad Pharmed Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 99. Espad Pharmed Injectable Deoxycholic Acid Product

Table 100. Espad Pharmed Recent Developments/Updates

Table 101. Curia Company Information

Table 102. Curia Description and Business Overview

Table 103. Curia Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 104. Curia Injectable Deoxycholic Acid Product

Table 105. Curia Recent Developments/Updates

Table 106. Marllor Biomedical Company Information

Table 107. Marllor Biomedical Description and Business Overview

Table 108. Marllor Biomedical Injectable Deoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 109. Marllor Biomedical Injectable Deoxycholic Acid Product

Table 110. Marllor Biomedical Recent Developments/Updates

Table 111. Key Raw Materials Lists

Table 112. Raw Materials Key Suppliers Lists

Table 113. Injectable Deoxycholic Acid Distributors List

Table 114. Injectable Deoxycholic Acid Customers List

Table 115. Injectable Deoxycholic Acid Market Trends

Table 116. Injectable Deoxycholic Acid Market Drivers

Table 117. Injectable Deoxycholic Acid Market Challenges

Table 118. Injectable Deoxycholic Acid Market Restraints

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

Table 122. Authors List of This Report

List of Figures

Figure 1. Product Picture of Injectable Deoxycholic Acid

Figure 2. Global Injectable Deoxycholic Acid Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Injectable Deoxycholic Acid Market Share by Type: 2025 & 2032

Figure 4. Pure Deoxycholic Acid Product Picture

Figure 5. Compound Formulations Product Picture

Figure 6. Global Injectable Deoxycholic Acid Market Value by Compliance Level (US$ Million), 2021–2032

Figure 7. Global Injectable Deoxycholic Acid Market Share by Compliance Level: 2025 vs 2032

Figure 8. Pharmaceutical Grade Product Picture

Figure 9. Medical Device Grade Product Picture

Figure 10. Cosmetic Grade Product Picture

Figure 11. Global Injectable Deoxycholic Acid Market Value by Application (US$ Million), 2021–2032

Figure 12. Global Injectable Deoxycholic Acid Market Share by Application: 2025 & 2032

Figure 13. Dermatology Clinics

Figure 14. Hospitals

Figure 15. Others

Figure 16. Global Injectable Deoxycholic Acid Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Injectable Deoxycholic Acid Market Size (US$ Million), 2021–2032

Figure 18. Global Injectable Deoxycholic Acid Sales (K Units), 2021–2032

Figure 19. Global Injectable Deoxycholic Acid Average Price (US$/Unit), 2021–2032

Figure 20. Injectable Deoxycholic Acid Report Years Considered

Figure 21. Injectable Deoxycholic Acid Sales Share by Manufacturers in 2025

Figure 22. Global Injectable Deoxycholic Acid Revenue Share by Manufacturers in 2025

Figure 23. Top 5 and Top 10 Global Injectable Deoxycholic Acid Players: Market Share by Revenue in Injectable Deoxycholic Acid in 2025

Figure 24. Injectable Deoxycholic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 25. Global Injectable Deoxycholic Acid Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 26. North America Injectable Deoxycholic Acid Sales Market Share by Country (2021–2032)

Figure 27. North America Injectable Deoxycholic Acid Revenue Market Share by Country (2021–2032)

Figure 28. United States Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Canada Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Europe Injectable Deoxycholic Acid Sales Market Share by Country (2021–2032)

Figure 31. Europe Injectable Deoxycholic Acid Revenue Market Share by Country (2021–2032)

Figure 32. Germany Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. France Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. U.K. Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Italy Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Russia Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Asia Pacific Injectable Deoxycholic Acid Sales Market Share by Region (2021–2032)

Figure 38. Asia Pacific Injectable Deoxycholic Acid Revenue Market Share by Region (2021–2032)

Figure 39. China Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Japan Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. South Korea Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. India Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Australia Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. China Taiwan Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Southeast Asia Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America Injectable Deoxycholic Acid Sales Market Share by Country (2021–2032)

Figure 47. Latin America Injectable Deoxycholic Acid Revenue Market Share by Country (2021–2032)

Figure 48. Mexico Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Colombia Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Middle East and Africa Injectable Deoxycholic Acid Sales Market Share by Country (2021–2032)

Figure 53. Middle East and Africa Injectable Deoxycholic Acid Revenue Market Share by Country (2021–2032)

Figure 54. Turkey Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Saudi Arabia Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. UAE Injectable Deoxycholic Acid Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Global Sales Market Share of Injectable Deoxycholic Acid by Type (2021–2032)

Figure 58. Global Revenue Market Share of Injectable Deoxycholic Acid by Type (2021–2032)

Figure 59. Global Injectable Deoxycholic Acid Price (US$/Unit) by Type (2021–2032)

Figure 60. Global Sales Market Share of Injectable Deoxycholic Acid by Application (2021–2032)

Figure 61. Global Revenue Market Share of Injectable Deoxycholic Acid by Application (2021–2032)

Figure 62. Global Injectable Deoxycholic Acid Price (US$/Unit) by Application (2021–2032)

Figure 63. Injectable Deoxycholic Acid Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions